Trials / Completed
CompletedNCT02907242
Revealed Versus Concealed Cerebroplacental Ratio
Revealed Versus Concealed Criteria for Placental Insufficiency in Unselected Obstetric Population in Late Pregnancy: a Multicenter Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11,582 (actual)
- Sponsor
- Hospital Clinic of Barcelona · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the role of an integrated strategy at selecting fetuses for delivery at term based on a combination of fetal biometry and cerebroplacental ratio (CPR) to reduce stillbirth rate and adverse perinatal outcome.
Detailed description
This is a multicenter, open-label randomized trial with groups in parallel. Singleton pregnancies are recruited after routine second trimester scan (19+0 to 22+6 weeks of gestation) and randomly allocated at that moment to revealed or concealed strategy. A routine scan will be booked at 36-37 weeks. For a reduction of the stillbirth rate of 3‰ (from 5‰ to 2‰), assuming a type I error of 5% and aiming for a power of 80% a total of 11,582 subjects (5791 per arm) were projected. The participating centers sum up 12,000 deliveries a year. It is not possible to blind participants, obstetricians, or outcome assessors to the study group. General hypothesis: A proportion of fetuses with "normal" growth as per current standards have placental insufficiency and restriction of their growth potential. These fetuses exhibit biophysical changes expressed by abnormal cerebroplacental ratio. A combination of this marker with fetal biometry for the detection of fetuses affected by fetal growth restriction could identify a group of babies on which labor induction once term is reached may prevent the occurrence of adverse outcomes. Specific hypothesis * The cerebroplacental ratio has predictive value in late pregnancy for placental insufficiency. * The cerebroplacental ratio could improve the effectiveness of late pregnancy screening for the prediction placental insufficiency-related complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Revealment | Cerebroplacental ratio revealment |
Timeline
- Start date
- 2016-05-04
- Primary completion
- 2022-01-06
- Completion
- 2022-01-06
- First posted
- 2016-09-20
- Last updated
- 2022-04-18
Locations
9 sites across 6 countries: Chile, Czechia, Israel, Mexico, Poland, Spain
Source: ClinicalTrials.gov record NCT02907242. Inclusion in this directory is not an endorsement.